J&J: Potential HIV vaccine falls short in mid-stage study

A potential HIV vaccine being developed by Johnson & Johnson did not provide protection against the virus in a mid-stage study, the drugmaker said Tuesday.

from FOX News https://ift.tt/3jytxB6